Additionally, Quanterix’s Simoa platform will be featured in over ... Its industry-leading precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have ...
Simoa® technology offers flexibility ... additional batches may be prepared to scale up production. Ahomebrewbead-based immunoassay begins with the capture and labeling of an analyte using ...
The researchers measured both proteins simultaneously using a 2-plex assay on a single molecule array (Simoa) platform. This technology, developed by biotech company Quanterix, was a breakthrough ...
Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results